1. Stem Cell as Vehicles of Antibody in Treatment of Lymphoma: a Novel and Potential Targeted Therapy
   Jiayi Zhang et al, 2021, Stem Cell Reviews and Reports CrossRef
2. Epithelial p53 Status Modifies Stromal-Epithelial Interactions During Basal-Like Breast Carcinogenesis
   Ashley M. Fuller et al, 2021, Journal of Mammary Gland Biology and Neoplasia CrossRef
3. Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity
   Pengchong Shi et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
4. B Cells versus T Cells in the Tumor Microenvironment of Malignant Lymphomas. Are the Lymphocytes Playing the Roles of Muhammad Ali versus George Foreman in Zaire 1974?
   Minodora Desmirean et al, 2020, Journal of Clinical Medicine CrossRef
5. Ex vivo culture of malignant primary B cells
   Morgane Canonne et al, 2022, Frontiers in Hematology CrossRef
6. Research progress in the PD-1/PD-L1 pathway and IL-17A in lymphomas
   null null et al, 2022, Aging Pathobiology and Therapeutics CrossRef
7. Construction of tandem diabody (IL-6/CD20)-secreting human umbilical cord mesenchymal stem cells and its experimental treatment on diffuse large B cell lymphoma
   Jiayi Zhang et al, 2022, Stem Cell Research & Therapy CrossRef
8. Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma
   Yu Zhang et al, 2023, Frontiers in Immunology CrossRef
9. The Role of Neutrophils in the Pathogenesis of Chronic Lymphocytic Leukemia
   Malgorzata Wachowska et al, 2021, International Journal of Molecular Sciences CrossRef
10. A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy
    Ana Victoria Casadesús et al, 2020, OncoImmunology CrossRef